Company Filing History:
2 out of 138 
1 out of 832,880 Years Active: 2018-2022
Title: Marija Tadin-Strapps: Innovator in Myostatin Research
Introduction
Marija Tadin-Strapps is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of biotechnology, particularly in the area of muscle performance and health. With a total of 3 patents to her name, her work focuses on innovative methods for delivering therapeutic agents that can enhance muscle mass and performance.
Latest Patents
One of her latest patents is titled "Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety." This invention provides methods for the in vivo delivery of small nucleic acid molecules capable of mediating RNA interference and reducing the expression of myostatin. The small nucleic acid molecules are introduced to a subject through systemic administration. Specifically, the invention relates to methods that involve the delivery of short interfering nucleic acid (siNA) molecules targeting a myostatin gene expressed by a subject. The siNA molecule is conjugated to a lipophilic moiety, such as cholesterol. The myostatin siNA conjugates delivered through these methods are useful for modulating the in vivo expression of myostatin, increasing muscle mass, and enhancing muscle performance. Furthermore, the disclosed methods are indicated for treating musculoskeletal diseases or disorders that adversely affect muscle conditions.
Career Highlights
Throughout her career, Marija has worked with notable companies, including Sirna Therapeutics, Inc. Her experience in the biotechnology sector has allowed her to develop groundbreaking solutions that address critical health issues related to muscle performance.
Collaborations
Marija has collaborated with several professionals in her field, including Tayeba Khan and Walter R. Strapps. These collaborations have contributed to her innovative research and development efforts.
Conclusion
Marija Tadin-Strapps is a leading inventor whose work in myostatin research has the potential to revolutionize treatments for muscle-related disorders. Her innovative patents and collaborations highlight her commitment to advancing biotechnology for improved health outcomes.